The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.
Nanobodies as therapeutics: big opportunities for small antibodies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–310 of 310
Apoptosis: A Two‐edged Sword in Aging
Warner, H. R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07917.x · Cited by 68
Pain, C., Dumont, J., & Dumoulin, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.01.012 · Cited by 67
Stijlemans, B., Caljon, G., Natesan, S. K. A., Saerens, D., Conrath, K., Pérez-Morga, D. L., Skepper, J. N., Nikolaou, A., Brys, L., Pays, É., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002072 · Cited by 66
Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
van Brussel, A. S. A., Adams, A. L. L., Oliveira, S., Dorresteijn, B., Khattabi, M. E., Vermeulen, J. F., van der Wall, E., Mali, W. P. T. M., Derksen, P. W. B., van Diest, P. J., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0909-6 · Cited by 66
Multiphoton imaging of tumor biomarkers with conjugates of single-domain antibodies and quantum dots
Hafian, H., Sukhanova, A. V., Turini, M., Chames, P., Baty, D., Pluot, M., Cohen, J. H. M., Nabiev, I. R., & Millot, J. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.014 · Cited by 65
Direct Injection of Functional Single-Domain Antibodies from E. coli into Human Cells
Blanco‐Toribio, A., Muyldermans, S., Frankel, G. M., & Fernández, L. Á. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015227 · Cited by 64
Harmsen, M. M., van Solt, C. B., Hoogendoorn, A., van Zijderveld, F., Niewold, T., & van der Meulen, J. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.09.005 · Cited by 64
Haqqani, A. S., Caram‐Salas, N. L., Ding, W., Brunette, E., Delaney, C. E., Baumann, E., Boileau, E., & Stanimirovic, D. B. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3004995 · Cited by 63
Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology
Klooster, R., Maassen, B., Stam, J. C., Hermans, P., ten Haaft, M. R., Detmers, F. J. M., de Haard, H., Post, J. A., & Verrips, C. T. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.04.005 · Cited by 63
Krüwel, T., Névoltris, D., Bode, J., Dullin, C., Baty, D., Chames, P., & Alves, F. (2016) · Scientific Reports · doi:10.1038/srep21834 · Cited by 63
Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier
Caljon, G., Caveliers, V., Lahoutte, T., Stijlemans, B., Ghassabeh, G. H., Abbeele, J. V. D., Smolders, I. J., BAETSELIER, P. D., Michotte, Y. M., Muyldermans, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01723.x · Cited by 62
Nanobodies as modulators of inflammation: potential applications for acute brain injury
Rissiek, B., Koch‐Nolte, F., & Magnus, T. U. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00344 · Cited by 61
Meddeb‐Mouelhi, F., Bouhaouala‐Zahar, B., Benlasfar, Z., Hammadi, M., Mejri, T., Moslah, M., Karoui, H., Khorchani, T., & Ayeb, M. E. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.10.021 · Cited by 60
Chartier, A., Raz, V., Sterrenburg, E., Verrips, C. T., van der Maarel, S. M., & Simonelig, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp101 · Cited by 60
Zheng, F., Put, S., Bouwens, L., Lahoutte, T., Matthys, P., Muyldermans, S., BAETSELIER, P. D., Devoogdt, N., Raes, G., & Schoonooghe, S. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.130617 · Cited by 60
Huntington's Disease: Pathological Mechanisms and Therapeutic Strategies
Ramaswamy, S., Shannon, K. M., & Kordower, J. H. (2007) · Cell Transplantation · doi:10.3727/000000007783464687 · Cited by 60
Rissiek, B., Haag, F., Boyer, O., Koch‐Nolte, F., & Adriouch, S. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_420 · Cited by 58
A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2‐Positive Breast Cancer Cells
Gray, M. A., Tao, R. N., DePorter, S. M., Spiegel, D. A., & McNaughton, B. R. (2015) · ChemBioChem · doi:10.1002/cbic.201500591 · Cited by 58
Nanobody-functionalized PEG-b-PCL polymersomes and their targeting study
Zou, T., Dembele, F., Beugnet, A., Sengmanivong, L., Trépout, S., Marco, S., de Marco, A., & Li, M. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.09.034 · Cited by 57
Rissiek, B., Danquah, W., Haag, F., & Koch‐Nolte, F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713407 · Cited by 57
Kijanka, M. M., van Brussel, A. S. A., van der Wall, E., Mali, W. P. T. M., van Diest, P. J., Henegouwen, P. M. P. V. B. E., & Oliveira, S. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0166-y · Cited by 57
Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel
Abbady, A. Q., Al-Mariri, A., Zarkawi, M., Alassad, A., & Muyldermans, S. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.04.004 · Cited by 56
Broisat, A., Toczek, J., Dumas, L. S., Ahmadi, M., Bacot, S., Perret, P., Slimani, L., Barone‐Rochette, G., Soubies, A., Devoogdt, N., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.143792 · Cited by 56
Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)
Tillib, S. V., Ivanova, T. I., Vasilev, L. A., Rutovskaya, M. V., Saakyan, S. A., Gribova, I. Y., Tutykhina, I. L., Sedova, E. S., Lysenko, A. A., Shmarov, M. M., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2012.12.014 · Cited by 54
Integrative Expression System for Delivery of Antibody Fragments by Lactobacilli
Martín, M. C., Pant, N., Ladero, V., Günaydın, G., Andersen, K. K., Álvarez, B., Martínez, N., Álvarez, M. A., Hammarström, L. L. G., & Marcotte, H. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02690-10 · Cited by 54
Gueorguieva, D., Li, S., Walsh, N., Mukerji, A., Tanha, J., & Pandey, S. (2006) · The FASEB Journal · doi:10.1096/fj.06-6306fje · Cited by 53
A novel nanobody against urease activity of Helicobacter pylori
Ardekani, L. S., Gargari, S. L. M., Rasooli, I., Rajabibazl, M., Mohammadi, M., Ebrahimizadeh, W., Bakherad, H., & Zare, H. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.02.015 · Cited by 52
Riazi, A., Strong, P. C. R., Coleman, R., Chen, W., Hirama, T., van Faassen, H., Henry, M., Logan, S. M., Szymanski, C. M., MacKenzie, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083928 · Cited by 51
Sepúlveda, J., Mukherjee, J., Tzipori, S. R., Simpson, L. L., & Shoemaker, C. B. (2009) · Infection and Immunity · doi:10.1128/iai.01084-09 · Cited by 49
Bannas, P., Well, L., Lenz, A., Rissiek, B., Haag, F., Schmid, J., Hochgräfe, K., Trepel, M., Adam, G., Ittrich, H., et al. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1548 · Cited by 49
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
McCoy, L. E., Rutten, L., Frampton, D., Anderson, I., Granger, L. A., Bashford-Rogers, R. J. M., Dekkers, G., Strokappe, N. M., Seaman, M. S., Koh, W., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004552 · Cited by 49
Anti‐c‐ MET Nanobody® – a new potential drug in multiple myeloma treatment
Slørdahl, T. S., Denayer, T., Moen, S. H., Standal, T., Børset, M., Ververken, C., & Rø, T. B. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12185 · Cited by 48
Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
Liu, M., Huang, Y., Hu, L., Liu, G., Hu, X., Liu, D., & Yang, X. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-68 · Cited by 47
Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility
Hussack, G., Riazi, A., Ryan, S., van Faassen, H., MacKenzie, R., Tanha, J., & Arbabi‐Ghahroudi, M. (2014) · Protein Engineering Design and Selection · doi:10.1093/protein/gzu011 · Cited by 47
Llama Nanoantibodies with Therapeutic Potential against Human Norovirus Diarrhea
Garaicoechea, L., Aguilar, A., Parra, G. I., Bok, M., Sosnovtsev, S. V., Canziani, G., Green, K. Y., Bok, K., & Parreño, V. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133665 · Cited by 47
Koh, W., Steffensen, S., González-Pajuelo, M., Hoorelbeke, B., Gorlani, A., Szynol, A., Quigley, A. F., Aasa-Chapman, M. M. I., de Haard, H., Verrips, T. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116699 · Cited by 46
Potential candidate camelid antibodies for the treatment of protein-misfolding diseases
David, M. A., Jones, D. R., & Tayebi, M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.05.001 · Cited by 46
Overbeke, W. V., Wongsantichon, J., Everaert, I., Verhelle, A., Zwaenepoel, O., Loonchanta, A., Burtnick, L. D., Ganck, A. D., Hochepied, T., Haigh, J. J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv010 · Cited by 46
Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody
Omidfar, K., Zanjani, F. S. A., Hagh, A. G., Azizi, M. D., Rasouli, S. J., & Kashanian, S. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2790-1 · Cited by 45
Nabuurs, R. J. A., Rutgers, K. S., Welling, M. M., Metaxas, A., de Backer, M. E., Rotman, M., Bacskai, B. J., van Buchem, M. A., van der Maarel, S. M., & van der Weerd, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038284 · Cited by 45
Pant, N., Marcotte, H., Hermans, P., Bezemer, S., Frenken, L. G. J., Johansen, K., & Hammarström, L. L. G. (2011) · Future Microbiology · doi:10.2217/fmb.11.32 · Cited by 45
Rizk, S. S., Łuchniak, A., Uysal, S., Brawley, C. M., Rock, R. S., & Kossiakoff, A. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904907106 · Cited by 44
Alzogaray, V., Danquah, W., Aguirre, A., Urrutia, M., Berguer, P. M., Véscovi, E. G., Haag, F., Koch‐Nolte, F., & Goldbaum, F. A. (2010) · The FASEB Journal · doi:10.1096/fj.10-162958 · Cited by 44
Selection of non-competitive leptin antagonists using a random nanobody-based approach
Zabeau, L., Verhee, A., Catteeuw, D., Faes, L., Seeuws, S., Decruy, T., Elewaut, D. S., Peelman, F., & Tavernier, J. H. (2011) · Biochemical Journal · doi:10.1042/bj20110438 · Cited by 44
Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase
Sofla, F. J. I., Rahbarizadeh, F., Ahmadvand, D., & Rasaee, M. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.015 · Cited by 43
A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines
Jones, D. R., Taylor, W. A., Bate, C., David, M. A., & Tayebi, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009804 · Cited by 42
Rudolph, M. J., Vance, D. J., Cheung, J., Franklin, M. C., Burshteyn, F., Cassidy, M. S., Gary, E. N., Herrera, C., Shoemaker, C. B., & Mantis, N. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.026 · Cited by 42
A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment
Farajpour, Z., Rahbarizadeh, F., Kazemi, B., & Ahmadvand, D. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.069 · Cited by 42
Zhu, M., Hu, Y., Li, G., Ou, W., Mao, P., Xin, S., & Wan, Y. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-528 · Cited by 41
Huang, Y., Nokhrin, S. M., Hassanzadeh‐Ghassabeh, G., Yu, C. H., Yang, H., Barry, A. N., Tonelli, M., Markley, J. L., Muyldermans, S., Dmitriev, O. Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580845 · Cited by 40
Scheuplein, F., Rissiek, B., Driver, J. P., Chen, Y., Koch‐Nolte, F., & SERREZE, D. V. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.012 · Cited by 40
Moayeri, M., Leysath, C. E., Tremblay, J. M., Vrentas, C. E., Crown, D., Leppla, S. H., & Shoemaker, C. B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627943 · Cited by 40
Habib, I., Smolarek, D., Hattab, C., Grodecka, M., Hassanzadeh‐Ghassabeh, G., Muyldermans, S., Sagan, S., Gutiérrez, C., Laperche, S., Kim, C. L. V., et al. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.03.020 · Cited by 39
Nanobody-Functionalized Polymersomes for Tumor-Vessel Targeting
Debets, M. F., Leenders, W. P. J., Verrijp, K. C. N., Zonjee, M., Meeuwissen, S. A., Otte‐Höller, I., & van Hest, J. C. M. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300039 · Cited by 39
Araste, F., Ebrahimizadeh, W., Rasooli, I., Rajabibazl, M., & Gargari, S. L. M. (2013) · Biotechnology Letters · doi:10.1007/s10529-013-1340-1 · Cited by 38
Ezzine, A., M’hirsi, S., Bouhaouala‐Zahar, B., Hmila, I., Baciou, L., & Marzouki, M. N. (2012) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.67 · Cited by 38
Intrabodies as Neuroprotective Therapeutics
Messer, A. C., & Joshi, S. N. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0193-6 · Cited by 38
Inhibition of Type VI Secretion by an Anti-TssM Llama Nanobody
Nguyen, V. S., Logger, L., Spinelli, S., Desmyter, A., Le, T. T., Kellenberger, C., Douzi, B., Durand, É., Roussel, A., Cascalès, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122187 · Cited by 38
Camelid‐derived heavy‐chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris
Baghban, R., Gargari, S. L. M., Rajabibazl, M., Nazarian, S., & Bakherad, H. (2014) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1226 · Cited by 38
Mukherjee, J., Dmitriev, I., Debatis, M., Tremblay, J. M., Beamer, G., Kashentseva, E. A., Curiel, D. T., & Shoemaker, C. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106422 · Cited by 37
Overbeke, W. V., Verhelle, A., Everaert, I., Zwaenepoel, O., Vandekerckhove, J. S., Cuvelier, C. A., Derave, W., & Gettemans, J. (2014) · Molecular Therapy · doi:10.1038/mt.2014.132 · Cited by 37
Krüger, C., Hultberg, A., Marcotte, H., Hermans, P., Bezemer, S., Frenken, L. G. J., & Hammarström, L. L. G. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0347-0 · Cited by 37
Herrera, C., Tremblay, J. M., Shoemaker, C. B., & Mantis, N. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658070 · Cited by 37
Isolation of Monoclonal Antibody Fragments from Phage Display Libraries
Arbabi‐Ghahroudi, M., Tanha, J., & MacKenzie, R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-565-1_20 · Cited by 35
Nanobody Mediated Inhibition of Attachment of F18 Fimbriae Expressing Escherichia coli
Moonens, K., Kerpel, M. D., Coddens, A., Cox, E., Pardon, E., Remaut, H. K., & Greve, H. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114691 · Cited by 35
Schotte, L., Strauss, M., Thys, B., Halewyck, H., Filman, D. J., Bostina, M., Hogle, J. M., & Rombaut, B. (2014) · Journal of Virology · doi:10.1128/jvi.03402-13 · Cited by 35
Khattabi, M. E., Adams, H., Heezius, E. C. J. M., Hermans, P., Detmers, F. J. M., Maassen, B., van der Ley, P., Tommassen, J., Verrips, T. C., & Stam, J. C. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00107-06 · Cited by 35
Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF
Ebrahimizadeh, W., Gargari, S. L. M., Javidan, Z., & Rajabibazl, M. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1695-y · Cited by 34
Small unilamellar vesicles: a platform technology for molecular imaging of brain tumors
Iqbal, U., Albaghdadi, H., Nieh, M., Tuor, U. I., Mester, Z., Stanimirovic, D. B., Katsaras, J., & Abulrob, A. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/19/195102 · Cited by 34
Heavy chain–only antibodies are spontaneously produced in light chain–deficient mice
Zou, X., Osborn, M. J., Bolland, D. J., Smith, J. A., Corcos, D., Hamon, M., Oxley, D., Hutchings, A., Morgan, G., Santos, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071155 · Cited by 34
Targeting of Human Antigen-Presenting Cell Subsets
Goyvaerts, C., Dingemans, J., Groeve, K. D., Heirman, C., Gulck, E. R. V., Vanham, G. L., BAETSELIER, P. D., Thielemans, K., Raes, G., & Breckpot, K. (2013) · Journal of Virology · doi:10.1128/jvi.01498-13 · Cited by 34
Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes
Obishakin, E., Stijlemans, B., Santi‐Rocca, J., Vandenberghe, I. H. M., Devreese, B. V., Muldermans, S., Bastin, P., & Magez, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115893 · Cited by 33
Expression of a Dromedary Heavy Chain-Only Antibody and B Cell Development in the Mouse
Zou, X., Smith, J. A., Nguyen, V. K., Ren, L., Luyten, K., Muyldermans, S., & Brüggemann, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3769 · Cited by 32
Boons, E., Li, G., Vanstreels, E., Vercruysse, T., Pannecouque, C. C., Vandamme, A., & Daelemans, D. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.10.007 · Cited by 32
Passive Immunization by Lactobacilli Expressing Single-Chain Antibodies Against Streptococcus mutans
Krüger, C., Hultberg, A., van Dolleweerd, C. J., Marcotte, H., & Hammarström, L. L. G. (2005) · Molecular Biotechnology · doi:10.1385/mb:31:3:221 · Cited by 32
Hmila, I., Cosyns, B., Tounsi, H., Roosens, B., Caveliers, V., Abderrazek, R. B., Boubaker, S., Muyldermans, S., Ayeb, M. E., Bouhaouala‐Zahar, B., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.033 · Cited by 32
Payandeh, Z., Rasooli, I., Gargari, S. L. M., Rajabibazl, M., & Ebrahimizadeh, W. (2014) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trt114 · Cited by 32
Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin
Swain, M. D., Anderson, G. P., Zabetakis, D., Bernstein, R. D., Liu, J. L., Sherwood, L. J., Hayhurst, A., & Goldman, E. R. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3905-3 · Cited by 31
Zheng, F., Devoogdt, N., Sparkes, A., Morias, Y., Abels, C., Stijlemans, B., Lahoutte, T., Muyldermans, S., BAETSELIER, P. D., Schoonooghe, S., et al. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.09.018 · Cited by 30
McMurphy, T. B., Xiao, R., Magee, D., Slater, A., Zabeau, L., Tavernier, J. H., & Cao, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089895 · Cited by 30
Rousserie, G., Grinevich, R., Brazhnik, K., Even-Desrumeaux, K., Réveil, B., Tabary, T., Chames, P., Baty, D., Cohen, J. H. M., Nabiev, I. R., et al. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.02.029 · Cited by 29
Vos, J. D., Mathijs, I., Xavier, C., Massa, S., Wernery, U., Bouwens, L., Lahoutte, T., Muyldermans, S., & Devoogdt, N. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0731-6 · Cited by 28
Sha, H., Li, R., Bian, X., Liu, Q., Xie, C., Xin, X., Kong, W., Qian, X., Jiang, X., Hu, W., et al. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.05.020 · Cited by 27
Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody
Lülf, S., Matz, J., Rouyez, M.-C., Järviluoma, A., Saksela, K., Bénichou, S., & Geyer, M. (2014) · Retrovirology · doi:10.1186/1742-4690-11-24 · Cited by 27
Günaydın, G., Álvarez, B., Lin, Y. Y., Hammarström, L. L. G., & Marcotte, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096409 · Cited by 26
Demeestere, D., Dejonckheere, E., Steeland, S., Hulpiau, P., Haustraete, J., Devoogdt, N., Wichert, R., Becker‐Pauly, C., Wonterghem, E. V., Dewaele, S., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.2 · Cited by 25
Self-citationHead‐to‐tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid
Winichayakul, S., Pernthaner, A., Scott, R., Vlaming, R., & Roberts, N. (2008) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20080076 · Cited by 24
Moonens, K., den Broeck, I. V., Okello, E., Pardon, E., Kerpel, M. D., Remaut, H. K., & Greve, H. D. (2015) · Veterinary Research · doi:10.1186/s13567-015-0151-x · Cited by 24
Adams, H., Horrevoets, W. M., Adema, S. M., Carr, H. E. V., van Woerden, R. E., Koster, M. C., & Tommassen, J. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.06.029 · Cited by 24
Pereira, S. D. S., Moreira-Dill, L. S., Morais, M. S. D. S., Prado, N. D. R., Barros, M. L., Koishi, A. C., Mazzarotto, G. A. C. A., Gonçalves, G. M., Zuliani, J. P., Calderón, L. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108067 · Cited by 23
Preferential Lentiviral Targeting of Astrocytes in the Central Nervous System
Fassler, M., Weissberg, I., Levy, N., Diaz‐Griffero, F., Monsonego, A., Friedman, A., & Taube, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076092 · Cited by 21
Rossotti, M. A., González‐Techera, A., Guarnaschelli, J., Yim, L., Camacho, X., Fernández, M., Cabral, P., Leizagoyen, C., Chabalgoity, J. A., & González‐Sapienza, G. (2015) · mAbs · doi:10.1080/19420862.2015.1068491 · Cited by 19
PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers
Tayebi, M., Jones, D. R., Taylor, W. A., Stileman, B. F., Chapman, C., Zhao, D., & David, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019998 · Cited by 19
Functional Mutations in and Characterization of VHH Against Helicobacter pylori Urease
Hoseinpoor, R., Gargari, S. L. M., Rasooli, I., Rajabibazl, M., & Shahi, B. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0750-4 · Cited by 19
Khamrui, S., Turley, S., Pardon, E., Steyaert, J., Fan, E., Verlinde, C. L. M. J., Bergman, L. W., & Hol, W. G. J. (2013) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2013.06.003 · Cited by 19
Adams, H., Horrevoets, W. M., Adema, S. M., Carr, H. E. V., van Woerden, R. E., Koster, M. C., & Tommassen, J. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.022 · Cited by 18
Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
Caljon, G., Stijlemans, B., Saerens, D., Abbeele, J. V. D., Muyldermans, S., Magez, S., & BAETSELIER, P. D. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001902 · Cited by 17
Selection and characterization of llama single domain antibodies against N-terminal huntingtin
Schut, M. H., Pepers, B. A., Klooster, R., van der Maarel, S. M., el Khatabi, M., Verrips, T. C., den Dunnen, J. T., van Ommen, G. B., & van Roon‐Mom, W. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1971-6 · Cited by 17
A novel nanobody specific for respiratory surfactant protein A has potential for lung targeting
Li, H., Wang, S., He, X., Li, N., Yu, F., Hu, Y., Wang, L., Zhang, P., Du, Y., Du, S.-S., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77268 · Cited by 16
Nunes-Silva, S., Gangnard, S., Vidal, M., Vuchelen, A., Dechavanne, S., Chan, S., Pardon, E., Steyaert, J., Ramboarina, S., Chêne, A., et al. (2014) · Scientific Reports · doi:10.1038/srep07373 · Cited by 15
Mapping the Binding Interface between an HIV-1 Inhibiting Intrabody and the Viral Protein Rev
Vercruysse, T., Boons, E., Venken, T., Vanstreels, E., Voet, A. R. D., Steyaert, J., Maeyer, M. D., & Daelemans, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060259 · Cited by 15
Biotinylated Bionanocapsules for Displaying Diverse Ligands Toward Cell-specific Delivery
Shishido, T., Azumi, Y., Nakanishi, T., Umetsu, M., Tanaka, T., Ogino, C., Fukuda, H., & Kondo, A. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp134 · Cited by 15
Selection and characterization of camelid nanobodies towards urokinase-type plasminogen activator
Kaczmarek, J. Z., & Skottrup, P. D. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.011 · Cited by 14
Herrera, C., Vance, D. J., Eisele, L. E., Shoemaker, C. B., & Mantis, N. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099788 · Cited by 14
Oligomer-targeting with a conformational antibody fragment promotes toxicity in Aβ-expressing flies
Wacker, J., Rönicke, R., Westermann, M., Wulff, M., Reymann, K. G., Dobson, C. M., Horn, U., Crowther, D. C., Luheshi, L. M., & Fändrich, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-43 · Cited by 14
Aggarwal, B. B. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38753 · Cited by 13
Rizk, S. S., Misiura, A., Paduch, M., & Kossiakoff, A. A. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200496e · Cited by 12
CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants
Dreja, H. S., Pade, C., Chen, L., & McKnight, Á. (2015) · Journal of General Virology · doi:10.1099/vir.0.000120 · Cited by 10
Intracellular antibodies: a revolution waiting to happen?
Stocks, M. (2006) · PubMed · Cited by 7
Camelid reporter gene imaging: a generic method for in vivo cell tracking
Goethals, L., Bos, T. J., Baeyens, L., Geeter, F. D., Devoogdt, N., & Lahoutte, T. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0032-8 · Cited by 4
Cited by
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Guo, K., Wustoni, S., Koklu, A., Díaz-Galicia, E., Moser, M., Hama, A., Alqahtani, A. A., Ahmad, A. N., Alhamlan, F. S., Shuaib, M., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00734-9 · Cited by 410
Purine Release, Metabolism, and Signaling in the Inflammatory Response
Linden, J., Koch-Nolte, F., & Dahl, G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052406 · Cited by 377
Metadata
- Authors
- Steeland, S., Vandenbroucke, R. E., & Libert, C.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 21
- Issue
- 7
- Pages
- 1076-1113
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2325393979
- Cited by
- 468
- References
- 310
- FWCI
- 30.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.